Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2003

View Archived Issues

Gastrointestinal safety of AZD-3582 demonstrated in humans

Efficacy and tolerance of MS-275 in patients with refractory tumors

Etanercept monotherapy for plaque psoriasis

Ximelagatran demonstrates efficacy in VTE

Beneficial effects of UCB-34714 in neuropathy and epilepsy

Antitumor effects of TZT-1027 in advanced cancer patients

Vernalis updates development status of key R&D programs

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Lorantis

Organon and CARIM join forces in atherosclerosis research

Wex updates Tectin progress

Novel MAO-B inhibitors and their use patented by Roche

New muscarinic antagonists identified at Schering

Aventis describes new series of Th2 cell modulators

New JNK3 inhibitors with potential utility in cerebral ischemia and other CNS disorders

Novel antibacterial agents covered by Bayer patent

Enanta team presents new semisynthetic macrolide antibiotics

NGF-modulating compound in development at Krenitsky for neurodegenerative conditions

Enrollment completed in phase IIa BPH study of BXL-628

BresaGen spin-off to create leading stem cell therapy company

Gadovist 1.0 receives E.U. approval for MRA

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Opexa Pharmaceuticals

Solvay describes preclinical studies with centrally available NK1 receptor antagonist SLV-323

ER-022604: a neurotrophic factor-like compound with potential in motoneuronal diseases

Inhibition of GSK-3beta reduces neuronal death in culture and in animal model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...